Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample

Thorax

Volumn 54, Issue 9, 1999, Pages 757-761

  Moffatt, Miriam F ^a   James, Alan ^b   Ryan, Gerard ^b   Musk, A William ^b   Cookson, William O C M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Asthma; Genetics; TNF HLA DR haplotypes; Tumour necrosis factor

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CYTOKINE; HLA DR ANTIGEN; STEROID; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; AUSTRALIA; BRONCHUS HYPERREACTIVITY; CHILD; CONTROLLED STUDY; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOGENETICS; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032778932     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.9.757     Document Type: Article

References (33)

1. 1 Strachan DP, Anderson HR, Limb ES, et al. A national survey of asthma prevalence, severity, and treatment in Great Britain. Arch Dis Child 1994;70:174-8.
2. 2 Fraser RS, Paré JAP, Fraser RG, et al. Synopsis of diseases of the chest. Philadelphia: WB Saunders, 1994: 635-53.
3. 3 Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
4. 4 Broide DH, Lotz M, Cuomo AJ, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
5. 5 Virchow J-C, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
6. 6 Dunham I, Sargent CA, Trowsdale J, et al. Molecular mapping of the human major histocompatibility complex by pulsed field electrophoresis. Proc Natl Acad Sci USA 1987;84:7237-41.
7. 7 Nedospasov SA, Shakov AN, Turetskaia RL, et al. Molecular cloning of human genes coding tumor necrosis factor: tandem arrangement of alpha- and beta-genes in a short segment (six thousand nucleotide pairs) of human genome. Doki Akad Nauk SSSR 1985;285:1487-90.
8. 8 Wilson AG, Symons JA, McDowell TL, et al. Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994;33:89.
9. 9 Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production, J Exp Med 1991;173:209-19.
10. 10 Jacob CO, Fronek Z, Lewis GD, et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
11. 11 Moffatt MF, Cookson WOCM. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997;6:551-4.
12. 12 Marsh DG, Meyers DA, Bias WB. The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551 9.
13. 13 Young RP, Dekker JW, Wordsworth BP, et al. HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431-9.
14. 14 Moffatt MF, Schou C, Faux JA, et al. Germ-line TCR-A restriction of immunoglobulin E responses to allergen. Immunogenetics 1997;46:226 30.
15. 15 Jorde L, Watkins WS, Carlson M, et al. Linkage disequilibrium in the adenomatous polyposis coli region. Am J Hum Genet 1995;54:884-98.
16. 16 Farewell VT, Dahlberg S. Some statistical methodology for the analysis of HLA data. Biometrics 1984;40:547-60.
17. 17 Beck H-P, Felger I, Barker M, et al. Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population. Am J Trop Med Hyg 1995;53:284-8.
18. 18 Hill MR, James AL, Faux JA, et al. FcERI-β and risk of atopy in a general population sample. BMJ 1995;311:776-9.
19. 19 Yan K, Salome CM, Woolcock AJ. Rapid method for measuring bronchial responsiveness. Thorax 1983;38:760-5.
20. 20 O'Connor G, Sparrow D, Taylor D, et al. Analysis of dose-response curves to methacholine: an approach suitable for population studies. Am Rev Respir Dis 1987;136:1412-7.
21. 21 Peat JK, Salome CM, Berry G, et al. Relation of dose-response slope to respiratory symptoms and lung function in a population study of adults living in Busselton, Western Australia. Am Rev Respir Dis 1992;146:860-5.
22. 22 Peat JK, Salome CM, Berry G, et al. Relation of dose-response slope to respiratory symptoms in a population of Australian schoolchildren. Am Rev Respir Dis 1991;144:663-7.
23. 23 Green PM, Bentley DR, Mibashan S, et al. Molecular pathology of haemophilia B. EMBO J 1989;8:1067-72.
24. 24 Wordsworth BP, Allsop CEM, Young RP, et al. HLA-DR typing using DNA amplification by polymerase chain reaction and sequential hybridisation to sequence specific oligonucleotide probes. Immunogenetics 1990;32:413-8.
25. 25 Elston RC, George VT, Sorant AJM. Trait-Marker association program. Part of the SAGE documentation. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, 1994.
26. 26 O'Connor GT, Weiss ST. Clinical and symptom measures. Am J Respir Crit Care Med 1994;149:S21-28.
27. 27 Woolcock AJ, Peat JK, Salome CM, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax 1987;42:361-8.
28. 28 Peat, JK, Haby M, Spijker J, et al. Prevalence of asthma in adults in Busselton, Western Australia. BMJ 1992;305:1326 9.
29. 29 Hopper J, Jenkins M, Carlin J, et al. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Publ Health 1995;19;120-4.
30. 30 George VT, Elston RC. Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol 1987;4:193-201.
31. 31 Pociot F, Wilson AG, Nerup J, et al. No independent association between a tumor necrosis factor-α promoter polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:3043-9.
32. 32 Renzetti LM, Paciorek PM, Tannu SA, et al. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther 1996;278:847 53.
33. 33 Drazen JM, Yabdava C, Pillari KH, et al. Relationship between 5-LO gene promoter mutations and lung function response to 5-LO inhibition. Am J Respir Crit Care Med 1997;155:A257.